High-throughput screening for soluble protein expression beta

In the context of the Partnership for Structural Biology (PSB), combinatorial approaches, screening and robotics are applied to develop novel methods to solve challenging problems of protein expression for structural biology.

Previous and current research

Developing new molecular biology methods and using them to work on difficult biological problems

Combinatorial methods (e.g. directed evolution, phage display) are used to address problems that are too complex for rational design approaches. Large random libraries of variants are constructed and screened to identify rare hits with the desired property.

In our ESPRIT process for example, all truncations of a target protein are generated and screened using advanced picking and arraying robotics. With such technologies in hand, we are able to study certain biological questions with advantages over classical approaches. The proteins we study are generally enzymes of biological and medicinal interest:

Influenza RNA polymerase

There is worldwide concern that currently circulating avian influenza viruses will cross the species barrier and become highly pathogenic, human transmissible strains with pandemic potential. This could result from residue changes in several influenza proteins, either by point mutations, or through shuffling of the segmented avian and mammalian viral genomes. We are now characterising the interactions of these mutants with host cell factors using both structural and biophysical methods with the aim of understanding mechanisms of influenza host specificity.

Human Kinases

Cells have intricate mechanisms of sensing and responding to environmental changes. Upon a stimulus detected by a cellular receptor the complex system of signal transduction is activated that results in changes in gene expression.

Protein kinases play a crucial role in cellular stress responses as mediators between the upstream receptor and downstream gene regulation and are key components in coping with changes in the intra-/extracellular environment. When these mechanisms malfunction, diseases such as excessive inflammation, autoimmune disorders and cancer can occur. Kinases therefore represent important pharmaceutical targets for drug design.

The multidomain nature of many kinases reflects the need to regulate the activity of the catalytic activity. We are screening for stable constructs that extend beyond the conserved regions of the catalytic domain, and well-expressed internal domains presumably implicated in complex formation or regulation.

Histone Deacetylases (HDACs)

Using our construct screening technology, we have identified well-expressing, catalytically active constructs of an HDAC involved in cholesterol homeostasis. Using these proteins, we are investigating how new inhibitors bind using X-ray crystallography and enzymatic inhibition assays.

Secondly, using a library-format protein interaction screen, we are trying to identify HDAC-interacting domains of cellular proteins. If identified, disruption of such protein-protein interactions suggests a new route towards specific HDAC inhibition.

lab equipment
Figure 1: Screening tens of thousands of expression constructs of a target gene. Constructs are made as a random library and printed on membranes for soluble expression analysis by hybridisation of fluorescent antibodies.
influenza polymerase visualisation
Figure 2: A previously unsuspected domain from influenza polymerase, identified by high throughput expression screening of tens of thousands of random DNA constructs, and structurally characterised by X-ray crystallography. A single mutation to lysine at residue 627 (A) can be responsible for the evolution of human influenza viruses from wild-type avian viruses that have a glutamic acid at this position (B). The mutation of residue 627 reinforces or disrupts a striking basic surface patch and we are seeking to understand how this affects polymerase function.

Future projects and goals

Difficult biological projects require advanced new tools. We will continue to develop expression methods to handle protein complexes, targets that require eukaryotic expression for correct folding, and possibly aspects of membrane proteins.

Each project uses “real” targets of interest and the aim is use method advancements to yield previously unobtainable biological knowledge. For example, we are testing permutations of influenza-influenza and influenza-host proteins with the aim of defining expressible, crystallisable protein complexes that should provide insights into virus host cell interactions.


More information

Services at EMBL Grenoble

EMBL Grenoble provides research services such as access to third-generation synchrotron beamlines for macromolecular crystallography at the ESRF, and instruments for neutron crystallography on the high-flux neutron source of the ILL.